Form 4 for ORIC Oric Pharmaceuticals, Inc.
Accepted 2025-07-02 00:00:00 ET · period of report 2025-07-01 · accession 0001415889-25-019000 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-07-02 | 2025-07-01 | ORIC | Piscitelli Dominic | CFO | S - Sale | $10.05 | -20.0K | 48.3K | -29% | -$201.0K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-07-01 | S | D | 20,000 | $10.05 | 48,317 | D | — | — | (F2) Represents the weighted average share price of an aggregate total of 20,000 shares sold in the price range of $10.00 to $10.135 by the Reporting Person. The Reporting Person undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price. |